Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InnovAge Holding (INNV) Cash & Equivalents (2020 - 2025)

InnovAge Holding (INNV) has disclosed Cash & Equivalents for 6 consecutive years, with $83.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 80.57% year-over-year to $83.2 million, compared with a TTM value of $83.2 million through Dec 2025, up 80.57%, and an annual FY2025 reading of $64.1 million, up 12.61% over the prior year.
  • Cash & Equivalents was $83.2 million for Q4 2025 at InnovAge Holding, up from $67.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $216.3 million in Q4 2021 and bottomed at $39.0 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $119.4 million, with a median of $88.4 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents tumbled 55.86% in 2024, then surged 80.57% in 2025.
  • Year by year, Cash & Equivalents stood at $216.3 million in 2021, then decreased by 12.99% to $188.2 million in 2022, then tumbled by 71.27% to $54.1 million in 2023, then fell by 14.8% to $46.1 million in 2024, then soared by 80.57% to $83.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for INNV at $83.2 million in Q4 2025, $67.1 million in Q3 2025, and $64.1 million in Q2 2025.